tiprankstipranks
Trending News
More News >
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
US Market

Ionis Pharmaceuticals (IONS) Blogger Opinions & Sentiment

Compare
1,475 Followers

Blogger Sentiment

Bullish: 100.00%
Sector Average
Bullish
IONS Blogger sentiment is based on 4 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
100% SeekingAlpha
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Ionis: Expected 2026 Launch Of Olezarsen In SHTG To Spur Leap In Revenue Growth
SeekingAlpha
Ionis: Dawnzera Approval Kicks Off New Era For Strikingly Undervalued Pharma
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of IONS?
Seeking Alpha’s Out of Ignorance has a Bullish Sentiment.
    What do Motley Fool contributors think of IONS?
    Currently there's no blogger sentiment for IONS.
    What Is IONS’s Blogger Sentiment?
    IONS’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for IONS?
      The most recent blogger prediction for IONS was made by Out of Ignorance, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          MRKMerck & Company
          BMYBristol-Myers Squibb
          NVONovo Nordisk
          CRSPCrispr Therapeutics AG
          VKTXViking Therapeutics